Global Cold Plasma Implant Treatment Devices Market - 2022-2029

Global Cold Plasma Implant Treatment Devices Market - 2022-2029

Market Overview

The global cold plasma implant treatment devices market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

Low-temperature plasma, often known as cold plasma, modifies biomaterial surfaces. Low-temperature plasma is made by converting a substance to gas then ionizing it with energy such as heat, direct or alternating electric current, radiation, or laser light. The most frequent plasma gas sources are oxygen, nitrogen, hydrogen, or agon. Cold plasmas effectively deactivate bacteria. Plasma treatment can be a revolutionary tissue-saving approach, as it allows for the cleaning of uneven structures and tiny channels within the diseased tooth.

Furthermore, low-temperature plasma is a promising way for suppressing microbe development, offering a viable alternative to traditional procedures such as high temperatures, radiation, filtration, and desiccation (drying), all of which have significant downsides.

Market Dynamics

The rise in the geriatric population, technological improvements in cold plasma implant treatment devices, an increase in orthopedic disorders, and an increase in dental caries are all driving the global cold plasma implant treatment devices market.

An increase in dental caries will drive the market growth

An increase in the elderly population fuels the growth of the cold plasma implant treatment devices market, technological advancements in cold plasma implant treatment devices, an increase in orthopedic conditions, an increase in dental caries, improved antimicrobial efficacy, and the prevention of cross-contamination. Furthermore, the market is expanding due to the increased use of cold plasma in wound healing, cancer treatment, and infectious illness treatment. Increased awareness of implant therapy devices and significant development potential in emerging regions will boost the market's growth prospects. Furthermore, advancements in the implant business have a substantial impact on market growth.

Many countries face significant health implications from oral diseases, which affect people throughout their lives, causing pain, discomfort, disfigurement, and even death.These diseases have risk factors in common with other major non-communicable diseases. (1) It is estimated that nearly 3.5 billion people are affected by oral diseases. (2) According to the Global Burden of Disease 2017, untreated dental caries (tooth decay) in permanent teeth is the most common health condition. (1) Dental caries of primary teeth affect more than 530 million children (milk teeth). Severe periodontal (gum) disease, which can lead to tooth loss, is very common, affecting nearly 10% of the global population.

Furthermore, the proportion of the world's population aged 60 and up will nearly double from 12 percent to 22 percent between 2015 and 2050.By 2023, the number of persons aged 60 and more will outweigh youngsters under five.By 2050, 80% of the world's elderly will live in low- and middle-income countries.The population is aging at a considerably higher rate than in the past.(Source :World Health Organization), this population will more likely to be suffered by bone disorders thus increasing the overall cold plasma implant treatment devices market.

High cost of the devices is likely to hamper the market growth

Companies always evaluate the benefits of technology concerning their investment and the time required to recover that cost while keeping their budget in mind. Cold plasma coating technologies are capital-intensive because the equipment used in these coating technologies, such as vacuum equipment, is expensive and requires special operating conditions, such as low temperatures and controlled vacuum conditions so the high cost of the devices and the scarcity of skilled professionals are expected to hamper the market growth.

COVID-19 Impact Analysis

The COVID-19 outbreak has caused havoc in the healthcare industry around the world. Numerous industries, including several subcategories of healthcare, have been forced to close their doors because of the disease temporarily. Furthermore, COVID-19 has had a detrimental impact on the market for cold plasma implant therapy devices. The lockdown around the world has touched every form of business. For example, non-essential enterprises such as retail stores with a physical location open to the public are closed. Recreational and entertainment companies such as gyms, movie theatres, art centers, race tracks, salons, and public and private social groups were also shuttered during the lockdown.

However, during the shutdown, important businesses such as grocery stores, pharmacies, and hospitals remained open. The lockdown did not apply to healthcare or public health workers. Workers who do crucial clinical research, development, and testing for COVID-19 response, for example, fall into this category. Physicians, dentists, psychologists, mid-level practitioners, nurses and assistants, and laboratory experts are among the excluded healthcare providers and carers. Numerous industries, including several subdomains of healthcare, were impacted and compelled to suspend operations due to the pandemic temporarily. Similarly, the sector of cold plasma implant therapeutic devices suffered a setback.

Major market participants were experiencing supply chain disruptions, and product demand was drastically reduced. Hospitals and clinics worldwide saw a significant drop in surgical procedure volumes in 2020, as healthcare systems reallocated resources to address the rising demands of COVID-19 patients. Furthermore, during the pandemic period, public health organizations worldwide have urged delaying or suspending elective procedures. Several orthopedic and dental elective operations have also been halted.

Segment Analysis

The handheld devices systems segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Based on type, the handheld devices accounted for the largest share of the global cold plasma implant treatment devices market in 2020. It is expected to continue to dominate throughout the forecast period. This is due to an increase in large-scale commercial systems, such as those used in pharmaceutical or medical device companies for implant treatment.

In July 2020,Stryker unveiled its new generation handheld robotics platform, the CORI Surgical System, and real intelligence brand enabling technology solutions. According to a report published by the World Health Organization in February 2021, 1.71 billion people worldwide have musculoskeletal disorders. With roughly 14.9 million instances accounting for 17 percent of all YLDs worldwide, they are the leading contributor to years lived with disability. These factors will drive the growth of the segment.

Geographical Analysis

North America region holds the largest market share of the global cold plasma implant treatment devices market

North America dominated the global cold plasma implant treatment devices market in 2020 and is expected to continue throughout the forecast period. This is due to a large population base, increased awareness of cold plasma implant treatment, and increased healthcare expenditure.

In addition, organic and inorganic strategies such as mergers and acquisitions and partnerships within key market players will strengthen their product portfolio in the studied market which will drive the market. Also, several product launches in the market will lead to lucrative growth of the market. For instance, in April 2020, Relyon Plasma GmbH has introduced the piezobrush PZ3 atmospheric plasma system. Furthermore, advancements in various cold plasma implant treatment devices from established key players, in the United States, are likely to drive the market growth in North America.

Competitive Landscape

The cold plasma implant treatment devices market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Tri-Star, Relyon-plasma, Inven Comm, Novaplasma, Tantec, Keylinktech,, Plasmatreat, Enercon Industries among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the cold plasma implant treatment devices market globally. For instance, on Feburary 2018, Henniker Plasma entered into a partnership with Irida (Spain), allowing it to strengthen its geographic presence in Spain.

Key Developments

On March 2019, Nordson Corporation introduced the flexTRAK-SHS automated plasma treatment system. The advanced automation of the FlexTRAK-SHS system enables simultaneous strip buffering and plasma processing for increased chamber utilization.

On November 2019, Plasmaguard, a nanocoating product from Europlasma, has been launched.

Relyon-Plasma

Overview:

Plasma systems manufacturer and developer specializing in plasma treatment for industrial and medical applications. Surface cleaning, surface activation, and germ reduction are all goods the company offers, allowing industry and medical sectors to lower pathogen concentrations.

Product Portfolio:

Piezobrush: Piezobrush PZ3 is a tiny plasma portable device designed in laboratories, predevelopment, and small series assembly. The Piezoelectric Direct Discharge (PDD®) technology generates cold-active plasma temperatures below 50°C with a maximum power usage of 18 W. The TDK piezo plasma generator CeraPlasTM – a high-voltage discharge device for generating cold atmospheric-pressure plasma – is at the heart of this portable plasma device. Plasma can effectively improve the surface energy of various materials while also reducing bacteria and smells.

Why Purchase the Report?

Visualize the composition of the global cold plasma implant treatment devices market segmentation by application, type, end user, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global cold plasma implant treatment devices Market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global cold plasma implant treatment devices market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global cold plasma implant treatment devices market report would provide access to an approximately 40+ market data table, 45+ figures, and in the range of 180-200 (approximate) pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers